Nuvation Bio Inc. (NUVB)
NYSE: NUVB
· Real-Time Price · USD
2.75
-0.01 (-0.36%)
At close: Aug 15, 2025, 1:14 PM
Nuvation Bio Revenue Breakdown
Period Ending | Dec 31, 2024 |
---|---|
License Revenue Revenue | 2.09M |
License Revenue Revenue Growth | n/a |
Revenue by Geography
Period Ending | Dec 31, 2024 |
---|---|
China Revenue | 5.2M |
China Revenue Growth | n/a |
Japan Revenue | 2.7M |
Japan Revenue Growth | n/a |
Operating Expense Breakdown
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 38.48M | 35.39M | 26.14M | 19.58M | 16.16M | 7.3M | 5.42M | 7.78M | 7.54M | 7.73M | 7.46M | 8.04M | 8.95M | 7.46M | 7.61M | 5.67M | 6.4M | 4.61M | 4.43M | 2.92M | 1.67M | 1.93M | 1.82M | 1.44M | 1.87M | 1.87M |
Selling, General, and Administrative Revenue Growth | +8.73% | +35.41% | +33.48% | +21.21% | +121.35% | +34.54% | -30.25% | +3.14% | -2.50% | +3.62% | -7.21% | -10.10% | +19.90% | -1.89% | +34.19% | -11.42% | +38.98% | +3.90% | +51.83% | +74.58% | -13.14% | +5.71% | +26.55% | -22.90% | 0.00% | n/a |
Research and Development Revenue | 27.36M | 24.6M | 29.3M | 27.73M | 29.25M | 12.84M | 15.35M | 18.56M | 18.59M | 18.79M | 16.87M | 21.29M | 28.92M | 20.73M | 22M | 17.12M | 14.03M | 15.88M | 9.34M | 8.63M | 7.34M | 7.29M | 8.8M | 4.04M | 6.13M | 6.13M |
Research and Development Revenue Growth | +11.22% | -16.03% | +5.65% | -5.18% | +127.74% | -16.34% | -17.29% | -0.16% | -1.05% | +11.36% | -20.77% | -26.37% | +39.52% | -5.79% | +28.50% | +22.00% | -11.62% | +70.08% | +8.22% | +17.45% | +0.69% | -17.10% | +118.04% | -34.21% | 0.00% | n/a |